Ronald J Falk Selected Research

Vasculitis (Vasculitides)

1/2022	Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity.
1/2022	Mechanisms of vascular damage in ANCA vasculitis.
1/2021	Treatment Updates in Antineutrophil Cytoplasmic Autoantibodies (ANCA) Vasculitis.
1/2020	Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN.
1/2020	Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis.
1/2020	ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation.
11/2019	Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
11/2019	Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis.
4/2019	Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
11/2018	Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald J Falk Research Topics

Disease

62	Vasculitis (Vasculitides) 01/2022 - 01/2001
26	Glomerulonephritis 09/2022 - 01/2001
18	Inflammation (Inflammations) 01/2021 - 11/2002
17	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 09/2022 - 09/2008
15	Chronic Kidney Failure (Chronic Renal Failure) 04/2019 - 08/2000
9	Lupus Nephritis 09/2022 - 01/2001
8	Infections 01/2022 - 09/2009
8	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2005
8	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2016 - 10/2002
6	Proteinuria 05/2020 - 07/2003
6	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2020 - 07/2003
6	Kidney Diseases (Kidney Disease) 01/2020 - 11/2005
6	Microscopic Polyangiitis 03/2016 - 10/2002
5	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2019 - 10/2003
5	Hemorrhage 06/2014 - 12/2003
4	IGA Glomerulonephritis (IGA Nephropathy) 09/2022 - 10/2003
4	Necrosis 01/2020 - 01/2013
4	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2019 - 03/2003
4	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 11/2018 - 12/2003
4	Churg-Strauss Syndrome (Allergic Angiitis) 03/2016 - 11/2004
4	Chronic Renal Insufficiency 02/2014 - 02/2007
3	Systemic Vasculitis 09/2018 - 10/2004
3	Nephritis 04/2013 - 01/2001
3	Periodontitis 04/2009 - 04/2005
2	Hematuria 09/2022 - 08/2004
2	Hypoalbuminemia 11/2019 - 06/2014
2	Fibrosis (Cirrhosis) 01/2018 - 07/2003
2	Disease Progression 01/2017 - 09/2009
2	Anemia 04/2014 - 05/2007
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2013 - 05/2005
2	Vascular Diseases (Vascular Disease) 12/2008 - 01/2004
2	Kidney Cortex Necrosis 07/2005 - 10/2002
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2004 - 01/2001
1	Obesity 01/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 05/2020
1	Venous Thromboembolism 11/2019
1	Rapidly progressive glomerulonephritis with pulmonary hemorrhage 11/2018
1	Asthma (Bronchial Asthma) 09/2018
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 09/2018
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2017
1	Lung Diseases (Lung Disease) 07/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2017

Drug/Important Bio-Agent (IBA)

69	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 09/2022 - 01/2001
25	Peroxidase (Myeloperoxidase)IBA 01/2022 - 10/2002
22	AutoantibodiesIBA 01/2021 - 10/2002
13	Myeloblastin (Proteinase 3)IBA 01/2022 - 09/2003
13	AntibodiesIBA 11/2018 - 10/2004
11	CreatinineIBA 05/2020 - 02/2004
10	Proteins (Proteins, Gene)FDA Link 05/2015 - 08/2004
8	AntigensIBA 01/2020 - 01/2002
8	AutoantigensIBA 01/2020 - 01/2005
6	Serum AlbuminIBA 05/2020 - 03/2007
6	Immunoglobulin G (IgG)IBA 01/2008 - 10/2002
5	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2018 - 03/2003
5	Pharmaceutical PreparationsIBA 01/2018 - 01/2002
5	Rituximab (Mabthera)FDA Link 01/2017 - 01/2007
5	EnzymesIBA 03/2016 - 09/2003
5	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2010 - 07/2003
4	GlucocorticoidsIBA 01/2020 - 07/2003
4	CytokinesIBA 03/2016 - 12/2002
4	AlbuminsIBA 06/2014 - 04/2004
3	Peptides (Polypeptides)IBA 01/2022 - 03/2011
3	Peptide Hydrolases (Proteases)FDA Link 11/2019 - 01/2004
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
3	Immunosuppressive Agents (Immunosuppressants)IBA 04/2015 - 01/2007
3	Hemoglobins (Hemoglobin)IBA 04/2014 - 05/2007
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2012 - 12/2005
3	Complement System Proteins (Complement)IBA 03/2011 - 07/2003
2	EpitopesIBA 01/2020 - 04/2013
2	Biological ProductsIBA 01/2019 - 01/2017
2	Immunoglobulin A (IgA)IBA 01/2019 - 10/2003
2	HematinicsIBA 04/2014 - 11/2011
2	Cytochrome P-450 CYP2C9IBA 02/2014 - 09/2009
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 09/2012 - 06/2010
2	Phosphorus (Red Phosphorus)IBA 11/2011 - 03/2007
2	IronIBA 11/2011 - 05/2007
2	SteroidsIBA 09/2008 - 03/2003
2	Silicon Dioxide (Silica)FDA LinkGeneric 03/2007 - 01/2001
2	Monoclonal AntibodiesIBA 01/2007 - 09/2003
2	Messenger RNA (mRNA)IBA 01/2004 - 10/2003
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2022
1	Dietary Fats (Dietary Fat)IBA 01/2022
1	KininsIBA 01/2020
1	Bradykinin Receptors (Bradykinin Receptor)IBA 01/2020
1	Thromboplastin (Tissue Factor)IBA 11/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	PeroxidasinIBA 11/2018
1	CollagenIBA 11/2018
1	Calcineurin InhibitorsIBA 03/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2016

Therapy/Procedure

16	Therapeutics 01/2022 - 07/2003
6	Renal Dialysis (Hemodialysis) 01/2017 - 08/2000
3	Plasma Exchange 01/2020 - 01/2008
2	Complementary Therapies (Alternative Medicine) 11/2014 - 07/2003
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2007 - 07/2005
1	Duration of Therapy 01/2021
1	Immunotherapy 10/2016
1	Transplantation 10/2016
1	Remission Induction 03/2016